Global Bacteriophages Therapy Market to 2032

Overview

The Global Bacteriophages Therapy Market is expected to reach a 75.57 USD Million by 2032 and is projected to grow at a CAGR of 5.66% from 2025 to 2032.

Revenue, 2024 (USD Million)
47.95
Forecast, 2032 (USD Million)
75.57
CAGR, 2024 - 2032
5.66%
Report Coverage
Global

Global Bacteriophages Therapy Market 2018-2032 USD Million

Global Bacteriophages Therapy Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 47.95 USD Million
  • Projected Market Size (2032): 75.57 USD Million
  • CAGR (2025-2032): 5.66%

Key Findings of Global Bacteriophages Therapy Market

  • The Global Bacteriophages Therapy Market was valued at 75.57 USD Million in 2024.
  • The Global Bacteriophages Therapy Market is likely to grow at a CAGR of 5.66% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Lytic in Type Segment accounted for the largest share of the market with a revenue of 44.27 USD Million
  • The fastest growing segment Supperative Skin Infections in Application Segment grew Fastest with a CAGR of 6.09% during the forecast period from 2024 to 2032.

Global Bacteriophages Therapy Market Scope

Global Bacteriophages Therapy Market Segmentation & Scope
Route Of Administration
  • Others
  • Parenteral
  • Dermal
  • Oral
Application
  • Lung And Pleural Infections
  • Supperative Skin Infections
  • Others
  • Bacterial Dysentery
  • Infections Of Skin And Nasal Mucosa
  • Postoperative Wound Infections
Base
  • Water-Soluble Jelly Base
  • Sterile Broth Culture
Type
  • Lysogenic
  • Lytic
Target
  • Salmonella
  • Streptococcus
  • Pseudomonas
  • Others
  • Escherichia coli
  • Staphylococcus
End User
  • Others
  • Academic Research & Institutes
  • Speciality Clinics
  • Hospitals
Distribution Channel
  • Third Party Distributors
  • Direct Tender

Global Bacteriophages Therapy Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 47.95 USD Million
Market Value in 2032 75.57 USD Million
CAGR (2025-2032) 5.66%
Historic Data 2016-2023
Market Segments Covered Route Of Administration,Application,Base,Type,Target,End User,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): Global, leading in terms of revenue 47.95 USD Million in 2024
    • Key Country: U.S., leading in terms of revenue with value of 18.18 USD Million in 2024.

Segments and Scope

  • Global Bacteriophages Therapy Market to 2032, By Route Of Administration
    • Oral is the largest segment in Global Bacteriophages Therapy Market to 2032 with a revenue of 21.73 USD Million in the year 2024.
    • Dermal is the Fastest growing segment in Global Bacteriophages Therapy Market to 2032 with a Growth rate of 5.41 % in forecast period 2025-2032.
  • Global Bacteriophages Therapy Market to 2032, By Application
    • Postoperative Wound Infections is the largest segment in Global Bacteriophages Therapy Market to 2032 with a revenue of 16.62 USD Million in the year 2024.
    • Supperative Skin Infections is the Fastest growing segment in Global Bacteriophages Therapy Market to 2032 with a Growth rate of 5.91 % in forecast period 2025-2032.
  • Global Bacteriophages Therapy Market to 2032, By Base
    • Sterile Broth Culture is the largest segment in Global Bacteriophages Therapy Market to 2032 with a revenue of 33.98 USD Million in the year 2024.
    • Sterile Broth Culture is the Fastest growing segment in Global Bacteriophages Therapy Market to 2032 with a Growth rate of 5.79 % in forecast period 2025-2032.
  • Global Bacteriophages Therapy Market to 2032, By Type
    • Lytic is the largest segment in Global Bacteriophages Therapy Market to 2032 with a revenue of 44.27 USD Million in the year 2024.
    • Lytic is the Fastest growing segment in Global Bacteriophages Therapy Market to 2032 with a Growth rate of 5.75 % in forecast period 2025-2032.
  • Global Bacteriophages Therapy Market to 2032, By Target
    • Staphylococcus is the largest segment in Global Bacteriophages Therapy Market to 2032 with a revenue of 12.96 USD Million in the year 2024.
    • Escherichia coli is the Fastest growing segment in Global Bacteriophages Therapy Market to 2032 with a Growth rate of 5.39 % in forecast period 2025-2032.
  • Global Bacteriophages Therapy Market to 2032, By End User
    • Hospitals is the largest segment in Global Bacteriophages Therapy Market to 2032 with a revenue of 18.23 USD Million in the year 2024.
    • Speciality Clinics is the Fastest growing segment in Global Bacteriophages Therapy Market to 2032 with a Growth rate of 5.42 % in forecast period 2025-2032.
  • Global Bacteriophages Therapy Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Global Bacteriophages Therapy Market to 2032 with a revenue of 43.48 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in Global Bacteriophages Therapy Market to 2032 with a Growth rate of 5.75 % in forecast period 2025-2032.

Global Bacteriophages Therapy Market Company Share Analysis

 
Company Name Company Share Analysis
Microgen
MICREOS
Intralytix, Inc.
LOCUS BIOSCIENCES, INC.
Phagelux, Inc.
Global Bacteriophages Therapy Market Company Share Analysis

Global Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million

Global Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million

Global Bacteriophages Therapy Market Company Profiling

Global Bacteriophages Therapy Market Company Profiling
Frequently Asked Questions
The Global Bacteriophages Therapy Market is segmented based on Segmentation Route Of Administration,Application,Base,Type,Target,End User,Distribution Channel.
Global Bacteriophages Therapy Market was valued at USD 47.95(Revenue in USD Million) in 2020.
Global Bacteriophages Therapy Market is projected to grow at a CAGR of 5.66% during the forecast period of 2024 to 2032.
The Lytic segment is expected to dominate the Global Bacteriophages Therapy Market, holding a largest market share of 44.27 USD Million in 2024

Global Bacteriophages Therapy Market Scope

Global Bacteriophages Therapy Market Segmentation & Scope
Route Of Administration
  • Others
  • Parenteral
  • Dermal
  • Oral
Application
  • Lung And Pleural Infections
  • Supperative Skin Infections
  • Others
  • Bacterial Dysentery
  • Infections Of Skin And Nasal Mucosa
  • Postoperative Wound Infections
Base
  • Water-Soluble Jelly Base
  • Sterile Broth Culture
Type
  • Lysogenic
  • Lytic
Target
  • Salmonella
  • Streptococcus
  • Pseudomonas
  • Others
  • Escherichia coli
  • Staphylococcus
End User
  • Others
  • Academic Research & Institutes
  • Speciality Clinics
  • Hospitals
Distribution Channel
  • Third Party Distributors
  • Direct Tender
Frequently Asked Questions
The Global Bacteriophages Therapy Market is segmented based on Segmentation Route Of Administration,Application,Base,Type,Target,End User,Distribution Channel.
Global Bacteriophages Therapy Market was valued at USD 47.95(Revenue in USD Million) in 2020.
Global Bacteriophages Therapy Market is projected to grow at a CAGR of 5.66% during the forecast period of 2024 to 2032.
The estimated market value of the Global Bacteriophages Therapy Market for final year is USD 75.57 (USD Million).

Global Bacteriophages Therapy Market Company Profiling

Global Bacteriophages Therapy Market Company Profiling
Frequently Asked Questions
The Global Bacteriophages Therapy Market is segmented based on Segmentation Route Of Administration,Application,Base,Type,Target,End User,Distribution Channel.
Global Bacteriophages Therapy Market was valued at USD 47.95(Revenue in USD Million) in 2020.
Global Bacteriophages Therapy Market is projected to grow at a CAGR of 5.66% during the forecast period of 2024 to 2032.
The estimated market value of the Global Bacteriophages Therapy Market for final year is USD 75.57 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.